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INTRODUCTION
Ophthalmoplegia is a rare but important complication of
snake bites. It is developed by neurotoxins in snake venom.
Neurotoxicity by snake venom is an indication of antivenom
therapy. Although ophthalmoplegia is not a lethal condition
following snake bites, the symptoms of diplopia and dizzi-
ness are emotionally devastating for patients and present diag-
nostic and therapeutic challenges to the physicians. Ophthal-
moplegia by snake venom and its managements have rarely
been reported in Korea (1, 2). 
The authors describe two cases of ophthalmoplegia follow-
ing snake bites, which did not improve with antivenom but
rapidly improved by anticholinesterase therapy. These findings
support the effectiveness of anticholinesterase in the manage-
ment of ophthalmoplegia by snake venom.
CASE REPORT
Case 1
A 10-yr-old girl presented with a painful swelling of the
right foot and diplopia. She was bitten on the toe about 6
hr prior to her admission by an unidentified snake inhabit-
ing in Korea. She had felt pain and swelling of the bite site
within several minutes, and was immediately taken to the
hospital. By the time she arrived at the primary health care
facility, local tissue edema was evident but systemic symptoms
were absent. After a wound management without antivenom
therapy, she was discharged. However, the pain aggravated
and the swelling of the bite sites progressed above the ankle.
After this time, the patient experinced new-onset diplopia.
On admission, she was alert and not so ill-looking. Initial
vital signs were normal. Hemorrhagic blisters, bloody woozy,
tender and erythematous swelling were noted at the bite site,
while the edema was more expanded to the proximal joint.
On eye examination, the visual acuity was 0.8/0.9 (OD/OS).
The pupils were equal in size with normal reflex. She had
right exotropia with a limitation of adduction (Fig. 1A). The
right eye could not cross the midline on leftward gaze (Fig.
1A). The abnormal laboratory data included white blood
cell count of 19,700/ L and serum creatine phosphokinase
(CPK) 425 U/L (normal range, 51-246). After a careful inter-
view and physical examination of the girl, we concluded that
the diplopia was of new onset, and the snake venom induced
the adduction deficit of her right eye.
An antivenom was infused immediately upon admission
because the patient had newly developed diplopia and her
pain and swelling aggravated. After the first infusion, her
pain improved and the rate of swelling decreased, but diplopia
persisted. The patient was treated with another dose of anti-
venom 4 hr after the initial dose, but still she complained of
persistent diplopia. On the 2nd day of admission, she received
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Anticholinesterase Therapy for Patients with Ophthalmoplegia 
Following Snake Bites
: Report of Two Cases
Although ophthalmoplegia following snake bites is not indicative of a serious neu-
rotoxic complication, symptoms of diplopia, dizziness and ocular discomfort can
be emotionally devastating for patients. The authors experienced two cases of
ophthalmoplegia following snake bites in Korea. The patients complained of diplopia
that had developed several hours after the snake bites. The diplopia did not improve
with antivenom treatment, but resolved completely after several injections of neostig-
mine.
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intravenous (IV) neostigmine 0.5 mg per 6 hr and IV atropine
0.5 mg per 12 hr following a tensilon test. The signs of re-
covery from double vision and from a difficulty in  focusing
became evident after two injections of neostigmine. After 5
injections of neostigmine on the 3rd day of admission, the
limitation of adduction in the right eye was completely re-
covered (Fig. 1B). She had a mild abdominal discomfort dur-
ing the treatment of neostigmine, but it was self-resolved.
The girl was discharged on the 8th day of admission with-
out any ocular symptoms.
Case 2 
A 13-yr-old boy was bitten by a snake on the right thumb
about 18 hr prior to his admission. He visited our hospital
because of a painful swelling of his right thumb and diffi-
culty in focusing. He was immediately taken to the primary
health care facility. After a wound management without anti-
venom therapy, he was discharged. However, the pain aggra-
vated and the swelling of the bite sites progressed above the
wrist. Headache and diplopia was newly developed at this
time.
His initial vital signs were stable. On eye examination,
the visual acuity was 0.9 (OU), and the pupils were equal in
size with normal reflex. Diplopia aggravated with a limited
motion of each eye on upward and inward gaze and on down-
ward and inward gaze (Fig. 2A). Other eye examinations were
normal. The laboratory data showed the prothrombin time
was 13.2 sec (69.2%), activated partial thromboplastin time
32.1 sec, serum CPK 1,071 U/L, AST/ALT 78/95 IU/L, and
urine myoglobin negative. We presumed that diplopia was
of new onset because the snake venom had induced the limi-
tation of ocular movement in each eye.
After the two doses of the antivenom, his pain improved,
but the diplopia persisted. On the 2nd day of admission, he
received IV neostigmine 0.5 mg per 6 hr and IV atropine
0.5 mg per 12 hr following a Tensilon test. The boy had a
similar clinical course as in Case 1. After the 3rd injection
of neostigmine, his ocular symptoms improved and after the
5th injection of neostigmine on the 3rd day of admission,
the limitation of ocular motion was fully resolved (Fig. 2).
We stopped neostigmine the day after the patient had full
movement of EOM. The elevated levels of serum CPK and
AST/ALT became normal without complications on the 3rd
day of admission. He was discharged on the 5th day of admis-
sion without any ocular symptoms.
Fig. 1. (A) Right exotropia with a limitation of adduction. (B) On the 3rd day of admission, the limitation of adduction in the right eye was
completely recovered after neostigmine therapy (Case 1).
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Fig. 2. (A) A limited motion of each eye on upward and inward gaze. (B) Resolution of ophthalmoplegia after the 5th injection of neostig-
mine (Case 2).
B
ADISCUSSION
Venomous snakes inhabiting in Korea are Agkistrodon sax-
atilis, Agkistrodon blomhoffi brevicaudus and Agkistrodon calagi-
nosus (1). The venoms of these snakes contain several enzymes
and cyclolysin, hematotoxin, and neurotoxin (2). Although
localized and systemic symptoms following snake bites are
induced by cyclolysin and hematotoxin, many polypeptide
neurotoxins cause muscle paralysis by blocking the nicotinic
acetylcholine receptors at the post-synaptic motor endplates,
or they affect the mode of neurotransmitter release at the pre-
synaptic motor nerve endings (3). 
Neurotoxic paralysis may also begin within the first hour
of snake bites and is seen first as ptosis, then blurred vision
and diplopia, followed by facial weakness and dysarthria. In
severe cases, weakness of the limbs, paralysis of respiration,
and fixed and dilated pupils may be observed (4). Our patients
experienced blurred vision or diplopia. Ocular examination
revealed adduction deficit in Case 1 and dysfunction of oblique
muscles of each eye in Case 2. From the history of the pre-
sent illness of the patient and also from the review of the lit-
erature, the snake bitten the girl and the boy would be Agk-
istrodon blomhoffi brevicaudus, known to be seen frequently in
Korea. Among the medically important snake species of the
Far East, bites by Agkistrodon blomhoffi usually do not cause
serious effects (5). In some reports, the most common cause
of eye symptoms following a snake bite is Agkistrodon blomhof-
fi (2). The most common eye symptom is ophthalmoplegia,
and the medial rectus muscle is commonly involved. Also
in our cases, the girl had paresis of the right medial rectus
muscle; but the boy an had incomplete motion of each eye
on upward and inward gaze and on downward and inward
gaze, due to dysfunctions of oblique muscles, which is con-
sidered as a rare complication. 
The main treatment of neurotoxic paralysis following snake
bites is an injection of antivenom (6, 7). Indications for anti-
venom are hemostatic disturbance, cardiovascular abnormali-
ties, neurotoxicity, elevated CPK and aminotransferases with
a definite sign of local envenomation, and others (5, 7). We
used a polyvalent anti-venom because it was difficult to iden-
tify species of the snake that had bitten the patients at the
time of the treatment. Swelling, pain, and bloody woozing
of the bite site were decreased following antivenom therapy,
and high CPK and aminotransferases became normal over a
short period. However, diplopia and ophthalmoplegia were
not recovered. 
To date, there is a lack of controlled studies evaluating thera-
py for ophthalmoplegia by snake venoms. Because the bind-
ing to the presynaptic portion is irreversible, clinical recov-
ery occurs slowly and only with the formation of a new neu-
romuscular junction. The binding of toxin to the postsynap-
tic portion, however, may act postsynaptically to produce a
competitive or noncompetitive acetylcholine receptor block-
ade (8). Although an antivenom may induce a certain degree
of reversal of the paralysis by postsynaptic neurotoxin, the
clinical recovery is, however, very slow. Anticholinesterase is
potentially useful as in patients with suspected myasthenia
gravis. Sung and Hah (2) reported a case of extraocular mus-
cle paresis following a snake bite. Their case was the paresis
of the left medial rectus muscle, and it took 14 days for the
patient to recover from the paresis whereas it took only 3 days
in our cases. They used only antivenom. The clinical response
to anticholinesterase was more likely to ensue when the post-
synaptic neurotoxin was predominant in the venom (9). All
patients with neurotoxic symptoms should have a Tensilon
test, and then the effects should be evaluated. If there is an
improvement of symptoms or if there are no symptoms of
cholinergic crisis such as muscle fasciculation, we recommend
the use of anticholinesterase for patients with neurotoxicity
following snake bites. 
Although ophthalmoplegia is a rare symptom of snake
bites, it may induce anxiety and ocular discomfort for a long
period. Treatment of anticholinesterase with antivenom may
facilitate the recovery from ophthalmoplegia.
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